一、基本信息
邱倩倩，女，1989年11月生，江苏南通人，博士，讲师。2012年在中国药科大学获得制药工程专业学士学位，2017年在中国药科大学硕博连读获得药物化学专业博士学位，2017年来校任教至今。
二、研究方向
新药分子设计、合成与生物活性研究
三、开设课程与教学成果
承担本科生无机及分析化学、药剂学、药学基础实验等课程的讲授。
四、科研项目与学术成果
1.科研项目、科研获奖、科研成果
主持国家自然科学基金1项，校级项目1项，参与1项国家新药创制重大专项，1项国家面上基金，指导大学生创新项目1项。
2.代表论文：
(1) Qianqian Qiu, Baomin Liu, Jian Cui, Zheng Li, Xin Deng, Hao Qiang, Jieming Li, Chen Liao, Bo Zhang, Wei Shi, Miaobo Pan, Wenlong Huang*, Hai Qian*. Design, Synthesis, and Pharmacological Characterization of N-(4-(2 (6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)yl)ethyl)phenyl) quinazolin-4-amine Derivatives: Novel Inhibitors Reversing P-glycoprotein-Mediated Multidrug Resistance, Journal of medicinal chemistry, 2017, 60 (8): 3289–3302.
(2) Qianqian Qiu，Wei Shi，Zheng Li, Bo Zhang, Miaobo Pan, Jian Cui, Yuxuan Dai, Wenlong Huang*, Hai Qian*. Exploration of 2-((Pyridin-4-ylmethyl) amino) nicotinamide Derivatives as Potent Reversal Agents against P-Glycoprotein-Mediated Multidrug Resistance. Journal of medicinal chemistry, 2017, 60(7): 2930–2943.
(3) Xin Deng#, Qianqian Qiu#(共一), Xuekun Wang, Wenlong Huang*, Hai Qian*. Design, Synthesis, and Biological Evaluation of Novel Cholesteryl Peptides with Anticancer and Multidrug Resistance-Reversing Activities. Chemical biology & drug design, 2016, 87(3): 374-381.
(4) Qianqian Qiu, Xin Deng, Lei Jiao, Tianxiao Zhao, Fanfei Meng, Wenlong Huang*, Hai Qian*, A High‐Sensitivity Coumarin‐Based Fluorescent Probe for Monitoring Hydrogen Sulfide in Living Cells, Chemical biology & drug design, 2015, 86(2): 173-179.
(5) Xin Deng#, Qianqian Qiu#(共一), Ke Ma, Xuekun Wang, Wenlong Huang*, Hai Qian*, Aliphatic acid-conjugated antimicrobial peptides–potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability, Organic & biomolecular chemistry, 2015, 13(28): 7673-7680..
(6) Xin Deng#, Qianqian Qiu#(共一), Ke Ma, Wenlong Huang*, Hai Qian*, Synthesis and in vitro anti-cancer evaluation of luteinizing hormone-releasing hormone-conjugated peptide, Amino acids, 2015, 47(11): 2359-2366.
(7) Baomin Liu#, Qianqian Qiu#(共一), Tianxiao Zhao, Lei Jiao, Yunman Li, Wenlong Huang*, Hai Qian*, 6, 7‐Dimethoxy‐2‐{2‐[4‐(1H‐1, 2, 3‐triazol‐1‐yl) phenyl] ethyl}‐1, 2, 3, 4‐tetrahydroisoquinolines as Superior Reversal Agents for P‐Glycoprotein‐Mediated Multidrug Resistance, ChemMedChem, 2015, 10(2), 336-344.
(8) Qianqian Qiu, Jingjie Wang, Xin Deng, Hai Qian, Haiyan Lin*, Wenlong Huang*, Synthesis of Carbamide Derivatives Bearing Tetrahydroisoquinoline Moieties and Biological Evaluation as Analgesia Drugs in Mice. Archiv der Pharmazie, 2015, 348(5), 347-352.
(9) Zheng Li, Qianqian Qiu, Xinqian Geng, Jianyong Yang, Wenlong Huang*, HaiQian*. Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs
in preclinical to phase II clinical development, Expert Opinion on Investigational Drugs, 2016, 25(8): 871-890.
(10) Xin Deng, Qianqian Qiu, Baowei Yang, Xuekun Wang, Wenlong Huang*, Hai Qian*. Design, synthesis and biological evaluation of novel peptides with anticancer and drug resistance-reversing activities, European journal of medicinal chemistry, 2015, 89: 540-548.
(11) Zheng Li, Qianqian Qiu, Xue Xu, Xuekun Wang, Lei Jiao, Xin Su, Miaobo Pan,
Wenlong Huang*, Hai Qian*. Design, synthesis and Structure–activity relationship studies of new thiazole-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes, European journal of medicinal chemistry, 2016, 113: 246-257.
五、获得荣誉
博士毕业论文被评为“2018年江苏省优秀博士学位论文”。
六、联系方式
通讯地址：盐城市希望大道南路2号盐城师范学院药学院
邮编：224051。
联系电话：0515-88258773
E-mail：qiuqianqian1117@163.com